Giant Biogene's Recovery Drivers Appear Clear to Bull -- Market Talk

Dow Jones12-03

0623 GMT - Chinese beauty products manufacturer Giant Biogene's recovery drivers appear clear to its bull at Citi. Analyst Tiffany Feng expects the company to resume growth in teens in 2026, citing the continuous expansion of self-livestreaming and mid-tier key opinion leader livestreaming, as well as a few major new products. Giant Biogene revised its 2025 outlook lower, which seems to be in line with the low end of market estimates, she says in a note. Citi cuts its target price to HK$44.60 from HK$55.40 but retains its buy rating, expecting that the worst has been priced in. Shares fall 3.5% to HK$38.32. (megan.cheah@wsj.com)

(END) Dow Jones Newswires

December 03, 2025 01:23 ET (06:23 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588903840?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-03 14:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588903840","market":"hk","top_or_hot":-1,"title":"Giant Biogene's Recovery Drivers Appear Clear to Bull -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0623 GMT - Chinese beauty products manufacturer <a href=\"https://laohu8.com/S/02367\">Giant Biogene</a>'s recovery drivers appear clear to its bull at Citi. Analyst Tiffany Feng expects the company to resume growth in teens in 2026, citing the continuous expansion of self-livestreaming and mid-tier key opinion leader livestreaming, as well as a few major new products. Giant Biogene revised its 2025 outlook lower, which seems to be in line with the low end of market estimates, she says in a note. Citi cuts its target price to HK$44.60 from HK$55.40 but retains its buy rating, expecting that the worst has been priced in. Shares fall 3.5% to HK$38.32. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 03, 2025 01:23 ET (06:23 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Giant Biogene's Recovery Drivers Appear Clear to Bull -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGiant Biogene's Recovery Drivers Appear Clear to Bull -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-03 14:23</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0623 GMT - Chinese beauty products manufacturer <a href=\"https://laohu8.com/S/02367\">Giant Biogene</a>'s recovery drivers appear clear to its bull at Citi. Analyst Tiffany Feng expects the company to resume growth in teens in 2026, citing the continuous expansion of self-livestreaming and mid-tier key opinion leader livestreaming, as well as a few major new products. Giant Biogene revised its 2025 outlook lower, which seems to be in line with the low end of market estimates, she says in a note. Citi cuts its target price to HK$44.60 from HK$55.40 but retains its buy rating, expecting that the worst has been priced in. Shares fall 3.5% to HK$38.32. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 03, 2025 01:23 ET (06:23 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1207","symbol_name":"个人用品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2588903840","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588903840","pubTimestamp":1764742980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0623 GMT - Chinese beauty products manufacturer Giant Biogene's recovery drivers appear clear to its bull at Citi. Analyst Tiffany Feng expects the company to resume growth in teens in 2026, citing the continuous expansion of self-livestreaming and mid-tier key opinion leader livestreaming, as well as a few major new products. Giant Biogene revised its 2025 outlook lower, which seems to be in line with the low end of market estimates, she says in a note. Citi cuts its target price to HK$44.60 from HK$55.40 but retains its buy rating, expecting that the worst has been priced in. Shares fall 3.5% to HK$38.32. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1207":"个人用品","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","02367":"巨子生物","SG9999004311.SGD":"Nikko AM Shenton Emerging Enterprise Discovery Fund SGD"},"translate_title":"巨头Biogene的复苏驱动因素对多头来说似乎很明确——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02367":0.9},"content_text":"0623 GMT - Chinese beauty products manufacturer Giant Biogene's recovery drivers appear clear to its bull at Citi. Analyst Tiffany Feng expects the company to resume growth in teens in 2026, citing the continuous expansion of self-livestreaming and mid-tier key opinion leader livestreaming, as well as a few major new products. Giant Biogene revised its 2025 outlook lower, which seems to be in line with the low end of market estimates, she says in a note. Citi cuts its target price to HK$44.60 from HK$55.40 but retains its buy rating, expecting that the worst has been priced in. Shares fall 3.5% to HK$38.32. (megan.cheah@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 03, 2025 01:23 ET (06:23 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588903840","isCrawlerRequest":true}